Search with one or more keywords

This page gives you access to all the studies carried out by French researchers, identified on Covid-19.

To view other resources related to Covid-19, click here.

xml
XML

Export to XML

Please choose the format :

XML
XML-DDI
pdf
PDF

Export to PDF

Which version do you want to export ?

Download full content
Download light content
csv
CSV (Excel)

Export to CSV

What sections do you want to export ?

Métadonnées
Identification
General Aspects
Scientific investigator(s) (Contact)
Collaborations
Funding
Governance of the database
Additional contact
Type of database
Database objective
Population type
Dates
Size of the database
Data
Procedures
Promotion
Access
Select all | Invert selection | No selection
Export to CSV

Covid-19 : 84 forms

Sorting of results :

HOME-CoV - Hospitalization or Outpatient ManagEment of patients with a proven or probable SARS-CoV-2 infection

Head : DOUILLET Delphine

Version 1
Voir
View
Overview

25

Last update : 02/03/2021

HOME-CoV - Hospitalization or Outpatient ManagEment of patients with a proven or probable SARS-CoV-2 infection

Head : DOUILLET Delphine

Main objective

the composite rate of adverse outcomes [ Time Frame: day 7 ]
Adverse outcomes include intubation with mechanical ventilation requirement and death (Stage ≥ 6 on "Ordinal Scale for Clinical Improvement" of the World Health Organization) within 7 days after inclusion.

Inclusion criteria

The rate of hospitalization [ Time Frame: 24 hours ]
The rate of patients hospitalized after admission to the emergency room including patients discharged home more than 24 hours after admission.

It will be analyzed in a hierarchical approach, only if first primary objective is positive i.e. non-inferiority of HOME-CoV strategy versus current practice on the rate of adverse outcomes.

Last update : 02/03/2021

Voir
View

LICORNE - Predictive factors for mortality at D28 for patients managed at Lille University Hospital for COVID-19

Head : CHOPIN Marie Charlotte
DEPLANQUE Dominique

Version 1
Voir
View
Overview

26

Last update : 05/05/2021

LICORNE - Predictive factors for mortality at D28 for patients managed at Lille University Hospital for COVID-19

Head : CHOPIN Marie Charlotte
DEPLANQUE Dominique

Main objective

The primary objective of this study is to identify the predictive factors for mortality at D28 of SARS-CoV-2 infection in patients managed for COVID-19 at Lille University Hospital, via the creation of an epidemiological, clinical, biological, immunological, genetic, microbiological, pathological, radiological and therapeutic database, indicating the results of functional tests.
NB: The analysis will exclude patients who are "confirmed cases" with serious SARS-CoV-2 infection managed in a conventional medicine department owing to the therapeutic limitations (TL) which existed prior to SARS-CoV-2 infection, due to incurable disease or underlying comorbidities.

Inclusion criteria

Any adult patient, "suspect patients", "possible cases", "probable cases" or "confirmed cases" of SARS-CoV-2 infection admitted to Lille University Hospital.

Last update : 05/05/2021

Voir
View

SISCOVID - Observational, prospective, multicentre cohort of patients followed up after hospitalisation to evaluate respiratory sequelae subsequent to SARS-CoV-2 (COVID-19) infection

Head : CALCAIANU George

Version 1
Voir
View
Overview

27

Last update : 05/03/2021

SISCOVID - Observational, prospective, multicentre cohort of patients followed up after hospitalisation to evaluate respiratory sequelae subsequent to SARS-CoV-2 (COVID-19) infection

Head : CALCAIANU George

Main objective

Evaluate the respiratory sequelae after SARS-CoV-2 infection in patients hospitalised for severe COVID-19 pneumonia requiring O2, with subsequent outpatient follow-up (6 months) by:
- Low-dose chest CT scan (LD-chest CT),
- Static lung function tests (LFT),
- Arterial blood gases in ambient air at rest (AA BG) and/or with oxygen (O2 BG),
- 6-minute walking test in ambient air (6WT AA) and/or with oxygen (6WT O2)

Inclusion criteria

Patient having received verbal information and not objecting to the study
Age >= 18 years inclusive
Patient hospitalised for severe COVID-19 pneumonia requiring O2
Patient having contracted SARS-CoV-2 infection proven by RT-PCR and/or retrospective serology and/or COVID-19 syndrome with chest CT scan consistent with infection (over the period from 1 March 2020 to 30 June 2020)

Last update : 05/03/2021

Voir
View

NICORISCOVID - Measurement of the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2

Head : KARMOCHKINE Marina, no

Version 1
Voir
View
Overview

28

Last update : 05/05/2021

NICORISCOVID - Measurement of the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2

Head : KARMOCHKINE Marina, no

Main objective

Measure the strength of the relationship between tobacco use and the RT-PCR test for SARS-CoV2

Inclusion criteria

Care personnel having attended the Hôtel-Dieu Hospital Covid screening centre for symptoms compatible with SARS-CoV2 infection,
-Aged over 18 years,
With an email address,
-Able to express non-objection (=questionnaire feedback

Last update : 05/05/2021

Voir
View

CERTIFY.HEALTH - Evaluation of the Certify.Health application as a digital resource for managing the COVID-19 pandemic

Head : BOSSON Jean-Luc, TIMC Laboratory - Themas team

Version 1
Voir
View
Overview

29

Last update : 05/05/2021

CERTIFY.HEALTH - Evaluation of the Certify.Health application as a digital resource for managing the COVID-19 pandemic

Head : BOSSON Jean-Luc, TIMC Laboratory - Themas team

Main objective

Evaluate the user-friendliness and acceptability of the Certify.Health application among healthcare personnel in healthcare, research and teaching facilities

Inclusion criteria

- Age ≥ 18 years
- Healthcare personnel in healthcare, research and teaching facilities, or a member of the home-care network:
• equipped with a smartphone which can run the electronic application (version of the participant’s Android or iOS operating system compatible with the application) and having an internet connection OR a computer with internet access
• agreeing to provide their mobile phone number to access the application and receive notifications
OR a resident in a selected nursing home

Last update : 05/05/2021

Voir
View

ComCor - Study of sociodemographic factors, behaviours and practices associated with SARS-CoV-2 infection (ComCor)

Head : Fontanet Arnaud, Emerging Diseases Epidemiology Unit

Version 1
Voir
View
Overview

30

Last update : 05/07/2021

ComCor - Study of sociodemographic factors, behaviours and practices associated with SARS-CoV-2 infection (ComCor)

Head : Fontanet Arnaud, Emerging Diseases Epidemiology Unit

Main objective

Identify the sociodemographic characteristics, places frequented, and behaviours associated with a risk of SARS-CoV-2 infection.

Inclusion criteria

All subjects:
o Adult subject
o Having agreed to take part in the study
o Index case:
o Cases identified in the COVID-19 screening information
system database, SIDEP
o With a positive test for SARS-CoV-2 by
RT-PCR on a nasopharyngeal or throat swab (or
any other sample for which current technology
indicates active infection if positive) within the past 14
days
o Close contact cases:
o Living in the same household (sharing the same
home) as the case having invited him/her to take part
o With a positive test for SARS-CoV-2 by RT-PCR on a nasopharyngeal or
throat swab (or any other sample for which current technology
indicates active infection if positive)
following contact with the index case
o Close contact controls:
o Living in the same household (sharing the same
home) as the case having invited him/her to take part
o With a negative test for SARS-CoV-2 by RT-PCR on a nasopharyngeal or
throat swab (or any other sample for which current technology
indicates active infection if positive)
following contact with the index case
o Distant contact controls:
o Selected by IPSOS based on criteria including age,
gender, and administrative department of residence (paired
with index cases)

Last update : 05/07/2021

Voir
View

Please wait...

Partners - FAQ - Contact - Site map - Legal notices - Administration - Updated on December 15 2020 - Version 4.10.05